CANNON MICHAEL D

Chief Executive Officer at SOCIAL REALITY · on record since Jan 22, 2004
Director at Moleculin Biotech, Inc. · on record since Jun 7, 2016
Director at Athenex, Inc. · on record since Jun 21, 2017
See Remarks at Athenex, Inc. · on record since Aug 21, 2018

Insider trading activity of CANNON MICHAEL D

Transactions on record: 39; since Jan 16, 2004

Open-market buys: 0

Open-market sells: 9; $5.1M

Companies traded: 3; last filing Nov 14, 2025

Figures computed from official regulatory filings — .

Companies where CANNON MICHAEL D has traded

Moleculin Biotech, Inc.10 tx · Nov 14, 2025
Athenex, Inc.3 tx · Aug 21, 2018
SOCIAL REALITY26 tx · $5.9M · Jan 22, 2004

Track record of CANNON MICHAEL D

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of CANNON MICHAEL D

Co-insiders of CANNON MICHAEL D

Adams Steven J.Athenex, Inc.
Advance Data Services LtdAthenex, Inc.
Annoni JoeAthenex, Inc.
Bair Teresa BrophyAthenex, Inc.
Beansprouts LtdAthenex, Inc.
CAMPBELL KIMAthenex, Inc.
Carlander Carrie ESOCIAL REALITY
Cermak ElizabethMoleculin Biotech, Inc.
Climaco John MMoleculin Biotech, Inc.
COLLA GIANPAOLOSOCIAL REALITY
Cook Timothy DeVereAthenex, Inc.
Davis Stephanie AAthenex, Inc.
DREYER DAVID CSOCIAL REALITY
EDELMAN JOSEPHAthenex, Inc.
FACH WESLEY NSOCIAL REALITY
Fok MansonAthenex, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Moleculin Biotech, Inc.	Nov 14, 2025	AwardD (derivative)	150,000	—	—	SEC
Moleculin Biotech, Inc.	Nov 6, 2024	AwardD (derivative)	10,000	—	—	SEC
Moleculin Biotech, Inc.	May 26, 2023	AwardD (derivative)	15,000	—	—	SEC
Moleculin Biotech, Inc.	Jun 9, 2021	AwardD (derivative)	10,000	—	—	SEC
Moleculin Biotech, Inc.	Jun 17, 2020	AwardD (derivative)	15,000	—	—	SEC
Moleculin Biotech, Inc.	Jul 15, 2019	AwardD (derivative)	35,000	—	—	SEC
Moleculin Biotech, Inc.	May 24, 2019	AwardD (derivative)	15,000	—	—	SEC
Athenex, Inc.	Aug 21, 2018	AwardD (derivative)	18,000	0.00 USD	—	SEC
Moleculin Biotech, Inc.	Jun 8, 2018	AwardD (derivative)	35,000	—	—	SEC
Athenex, Inc.	Apr 27, 2018	AwardD (derivative)	18,000	0.00 USD	—	SEC
Moleculin Biotech, Inc.	Jul 26, 2017	AwardD (derivative)	15,000	—	—	SEC
Athenex, Inc.	Jun 21, 2017	AwardD (derivative)	18,000	0.00 USD	—	SEC
Moleculin Biotech, Inc.	Sep 27, 2016	AwardD (derivative)	20,000	—	—	SEC
SOCIAL REALITY	Jan 22, 2004	Sell	-9,500	27.65 USD	$262.6K	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	15,000	15.19 USD	$227.9K	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	9,500	13.75 USD	$130.6K	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	54	27.60 USD	$1.5K	SEC
SOCIAL REALITY	Jan 22, 2004	ExerciseD (derivative)	-9,500	0.00 USD	—	SEC
SOCIAL REALITY	Jan 22, 2004	ExerciseD (derivative)	-15,000	0.00 USD	—	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	10,000	4.53 USD	$45.3K	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	6,544	9.75 USD	$63.8K	SEC
SOCIAL REALITY	Jan 22, 2004	Sell	-6,544	27.65 USD	$180.9K	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	50,386	4.63 USD	$233K	SEC
SOCIAL REALITY	Jan 22, 2004	ExerciseD (derivative)	-10,000	0.00 USD	—	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	15,000	3.75 USD	$56.3K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Moleculin Biotech, Inc.	Nov 14, 2025	AwardD (derivative)	150,000	—	—	SEC
Moleculin Biotech, Inc.	Nov 6, 2024	AwardD (derivative)	10,000	—	—	SEC
Moleculin Biotech, Inc.	May 26, 2023	AwardD (derivative)	15,000	—	—	SEC
Moleculin Biotech, Inc.	Jun 9, 2021	AwardD (derivative)	10,000	—	—	SEC
Moleculin Biotech, Inc.	Jun 17, 2020	AwardD (derivative)	15,000	—	—	SEC
Moleculin Biotech, Inc.	Jul 15, 2019	AwardD (derivative)	35,000	—	—	SEC
Moleculin Biotech, Inc.	May 24, 2019	AwardD (derivative)	15,000	—	—	SEC
Athenex, Inc.	Aug 21, 2018	AwardD (derivative)	18,000	0.00 USD	—	SEC
Moleculin Biotech, Inc.	Jun 8, 2018	AwardD (derivative)	35,000	—	—	SEC
Athenex, Inc.	Apr 27, 2018	AwardD (derivative)	18,000	0.00 USD	—	SEC
Moleculin Biotech, Inc.	Jul 26, 2017	AwardD (derivative)	15,000	—	—	SEC
Athenex, Inc.	Jun 21, 2017	AwardD (derivative)	18,000	0.00 USD	—	SEC
Moleculin Biotech, Inc.	Sep 27, 2016	AwardD (derivative)	20,000	—	—	SEC
SOCIAL REALITY	Jan 22, 2004	Sell	-9,500	27.65 USD	$262.6K	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	15,000	15.19 USD	$227.9K	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	9,500	13.75 USD	$130.6K	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	54	27.60 USD	$1.5K	SEC
SOCIAL REALITY	Jan 22, 2004	ExerciseD (derivative)	-9,500	0.00 USD	—	SEC
SOCIAL REALITY	Jan 22, 2004	ExerciseD (derivative)	-15,000	0.00 USD	—	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	10,000	4.53 USD	$45.3K	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	6,544	9.75 USD	$63.8K	SEC
SOCIAL REALITY	Jan 22, 2004	Sell	-6,544	27.65 USD	$180.9K	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	50,386	4.63 USD	$233K	SEC
SOCIAL REALITY	Jan 22, 2004	ExerciseD (derivative)	-10,000	0.00 USD	—	SEC
SOCIAL REALITY	Jan 22, 2004	Exercise	15,000	3.75 USD	$56.3K	SEC